- Lobbying
- Lobbying by Otsuka America Pharmaceutical, Inc.
Lobbying Relationship
Bills mentioned
H.R.1458: Access to Prescription Digital Therapeutics Act of 2023
Sponsor: Kevin Hern (R-Okla.)
S.723: Access to Prescription Digital Therapeutics Act of 2023
Sponsor: Jeanne Shaheen (D-N.H.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
John Kevin Brennan | Chief of Staff, Rep. Rosa DeLauro (D-CT); Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate